stockrowTakeda Pharmaceutical Co.
TAK Healthcare Drug Manufacturers Specialty & Generic
Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.
- Revenue
- +1.71%
- EPS
- −4.35%
- Free cash flow
- +54.9%
- Total debt
- −7.28%
Quarter to September 2026, against a year earlier
Follow TAK
Alert me
Takeda Pharmaceutical Co. (TAK) Operating margin
Takeda Pharmaceutical Co.'s operating margin over the twelve months to 30 June 2026 was 11.6%, up 11.5 percentage points from fiscal 2026 (0.14%). Over the past ten years it has ranged from −7.27% (fiscal 2015) to 78.1% (fiscal 2021); the current reading is higher than 17% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | 0.14% | (7.34) |
| FY2025 | 7.48% | 2.46 |
| FY2024 | 5.02% | (7.16) |
| FY2023 | 12.2% | (0.73) |
| FY2022 | 12.9% | (65.20) |
| FY2021 | 78.1% | 75.06 |
| FY2020 | 3.05% | (6.72) |
| FY2019 | 9.77% | (3.89) |
| FY2018 | 13.7% | 4.66 |
| FY2017 | 9.00% | 1.76 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 16.5% | (0.17) |
| Jun 2025 | 16.7% | 2.91 |
| Jun 2024 | 13.8% | 15.59 |
| Mar 2024 | −1.82% | (11.26) |
| 25 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| UTHR United Therapeutics Corporation compare | 41.5% |
| ZTS Zoetis Inc. compare | 37.1% |
| NBIX Neurocrine Biosciences, Inc. compare | 24.0% |
| HLN Haleon PLC Sponsored ADR compare | 17.9% |
| TAK Takeda Pharmaceutical Co. | 11.6% |
| RDY Dr. Reddy's Laboratories Ltd compare | 9.20% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 7.84% |
| ELAN Elanco Animal Health Incorporated compare | 1.61% |
| VTRS Viatris Inc. compare | −0.03% |
| Drug Manufacturers Specialty & Generic industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on TAK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement